Plasma prostanoids in pregnancy‐induced hypertension

Publisher Website
Google Scholar
Abstract
Summary. The concentrations of 13,14‐dihydro‐15‐oxo‐prostaglandin F2α (PGFM), 6‐oxo‐prostaglandin F1α,a (6‐oxo‐PGF1α) and thromboxane B2 (T×B2) were measured by radioimmunoassay in peripheral plasma from 183 pregnant women attending routine antenatal clinics. A total of 141 patients (47 nulliparous, 94 parous) remained normotensive and had uncomplicated pregnancies. The results from this group showed that there was no significant difference in the concentration of any metabolite in relation to parity or gestational age. The concentrations (pmol/1; means±SD) were PGFM 373±105, 6‐oxo‐PGF1α 391±104 and T×B2 373±121. Nineteen patients (12 nulliparous, 7 parous) who had pregnancy‐induced hypertension (PIH) by the time of sampling (three) or who subsequently developed the symptom (mean time from sampling to diagnosis 11 weeks, range 1–24 weeks) had significantly higher levels of 6‐oxo‐PGFlα(574±216; P2 (603±268; P 3α and 754±228 pmol/1 for T×B2.